Vega Testing

Vega testing is Helmut Schimmel's 1970s modification of Voll's method: an EAV-type electrodermal circuit into which coded ampoules — vials said to represent allergens, toxins, or remedies — are placed, the operator reading the resulting impedance as a detection of allergy or toxic load. It belongs to the Electroceuticals / Bioelectronic Medicine family and shares the defining shape of its parent: a real instrument carrying an interpretation that did not survive testing.

The real substrate — the same electrodermal measurement

The substrate is identical to EAV's. A Vega device applies a small voltage across the skin and records the current; skin impedance is a real, measurable quantity, and the instrument records real data. Nothing about the measurement is fictional — the ammeter reads what flows. As with EAV, the atlas keeps open the question of whether any valid, modern interpretation of electrodermal data exists; that openness is the “keep” half of the entry. What Vega adds to the parent method is the ampoule in the circuit, and that addition is precisely where the claim becomes testable and breaks.

Claim vs evidence — why grade F

The claim is concrete: that placing a coded ampoule into the circuit shifts the reading in a way that “detects” an allergy or toxin. Under blinding, operators perform no better than chance — the readings do not distinguish the substances they are said to identify, and provocation of the ampoule does not produce a reproducible, condition-specific signal. That is tested-and-failed, which is what grade F records: not an absence of data but a negative result. The electrodermal substrate is real; the ampoule-allergy interpretation is what failed. The same Lancet Oncology review that frames this class of unconventional diagnostics applies here (Lancet Oncology, 2000).

Why this tier — and the “tested, not confirmed” sub-state

Vega sits in the Not-confirmed tier under the tested — not confirmed sub-badge. This is not incoherent hardware or impossible physics; it is a real instrument whose interpretation was put to a blinded test and did not pass. Keep the axes separate. The measurement's plausibility is genuine — it really records impedance. The plausibility of the detection claim is low, since blinded operators sit at chance. The grade is F for that claim. A real measurement does not promote a failed interpretation, and a failed interpretation does not erase the real measurement — tier, grade, and plausibility move on independent axes here.

Regulatory — no diagnostic clearance

No jurisdiction clears Vega as a diagnostic. There is no diagnostic clearance in the US or the EU, and none identified in Russia, China, or Australia; the devices move through the used-device and practitioner market. There is no registration to mistake for efficacy — the market-access fact itself is absent for the diagnostic claim.

Lineage — the Abrams-era root, one step on from Voll

Vega is one generation downstream of EAV and, through it, of the Abrams-era radionics tradition mapped on the lineage page — the early-twentieth-century premise that disease carries an electrical signature a device can read off the body. Schimmel's contribution was the coded ampoule; the underlying electrodermal substrate, and its testing record, came straight from Voll.

Keep vs set aside

Keep: the electrodermal measurement and the working instrument behind it — real data from a real voltmeter and ammeter — and the open question of whether a valid, modern reading of skin-impedance data exists at all. The honest reinterpretation is the same as for EAV: what failed was one specific interpretation, not the act of measuring. Set aside: the ampoule-in-circuit allergy and toxin interpretation, which was tested, was not confirmed, and is rejected. The instrument and its raw signal remain; the diagnostic story laid over them does not.